Vitamin D3 for Life

Live Enlightened

Article

Why a Vitamin D Deficiency Threshold Is Not the Same as a Functional Target

Previous related pageWhat Circulating Vitamin D Levels Measure: Biomarker Status Versus Biological Effect: Study SummaryNext related pageWhy Measured Vitamin D Levels Can Diverge from Functional Biological Outcomes: Full Study
Study at a glance

What is the difference between a vitamin D threshold and a target?

A threshold marks a boundary used to identify concern or guide a decision. A target is a level someone aims to reach. Evidence supporting the boundary does not automatically prove the value of a higher target.

Does preventing vitamin D deficiency mean that more is always better?

No. Preventing harm from too little vitamin D and gaining extra benefit from more vitamin D are separate questions. The second needs its own evidence.

What would justify a higher vitamin D target?

Evidence that reaching that level improves a meaningful outcome in the relevant group, with acceptable risks. A blood level seen in healthy people or a theoretical benefit is not enough on its own.

Read the full article below ↓

Vitamin D discussions often move too quickly from “below this concentration may be too low” to “therefore everyone should aim for this higher concentration.” Those statements are not logically equivalent. A deficiency threshold marks a boundary of concern for a defined purpose. A functional target proposes a destination that is expected to produce additional benefit. The first can be supported even when the second remains uncertain. This Context page develops the interpretive distinction surrounding Vitamin D Thresholds vs Targets.

A threshold defines when concern becomes justified

At very low vitamin D status, the evidence becomes increasingly consistent that mineral physiology can be impaired. The risks of rickets, osteomalacia, secondary hyperparathyroidism and disturbed calcium handling become more important as depletion becomes severe. A deficiency threshold attempts to identify a region of the continuum where that risk is high enough to justify classification or action.

That is different from saying that the threshold itself represents ideal physiology. The threshold may simply identify the concentration below which risk becomes unacceptable. Vitamin D Deficiency Definitions explains why different organisations can legitimately use different boundaries when their purposes and evidence differ.

A target makes an additional claim

A functional target says more. It implies that aiming for a specified concentration or range improves a meaningful physiological or clinical endpoint. If the target is 30 ng/mL rather than 20 ng/mL, the evidence must therefore show why raising people from the lower region into the higher region produces sufficient additional benefit to justify that target.

The fact that severe deficiency causes problems does not provide that evidence by itself. This is analogous to many biological variables: avoiding an abnormally low value does not prove that progressively higher values continue to improve function.

PTH and calcium absorption illustrate the difficulty

PTH suppression has often been used as a proposed marker of vitamin D adequacy. The inverse relationship between 25(OH)D and PTH is biologically real, but reported inflection points differ between populations and methods. PTH is influenced by renal function, age, calcium intake and other factors, so one universal plateau is difficult to establish.

Calcium absorption likewise provides strong evidence that vitamin D matters when status is very low, but randomised evidence has not shown a simple higher concentration at which absorption suddenly becomes optimal. In one trial of older women, substantial increases in 25(OH)D produced only a modest increase in calcium absorption across a broad range.

These observations are consistent with Why Vitamin D Insufficiency Is Not a Universal Cut-Off: real physiology can exist without one universal numerical breakpoint.

Population adequacy is not individual optimisation

The Institute of Medicine concluded that 20 ng/mL would meet the vitamin D requirements of nearly all individuals under its skeletal-health population model. That is a population adequacy statement. It is not a declaration that every person at 20 ng/mL has maximised every vitamin D-dependent function.

Similarly, a higher concentration observed in healthy populations does not automatically become an individual treatment target. Population Reference Ranges Explained shows why descriptive population ranges, adequacy criteria and therapeutic targets need different evidential foundations.

The 2024 guideline change illustrates the distinction

The Endocrine Society’s 2011 guideline used 30 ng/mL as its sufficiency boundary. In 2024, after reviewing newer randomised evidence, the Society no longer endorsed that universal definition for generally healthy populations. Its panel concluded that available clinical trials did not identify 25(OH)D thresholds that specifically predicted meaningful benefit from supplementation.

This did not abolish vitamin D deficiency. It showed that recognising harmful depletion and proving a higher optimisation target are different evidential tasks.

A useful interpretation keeps the questions separate

When interpreting a vitamin D number, ask what the number is supposed to do. Is it identifying severe deficiency? Estimating population adequacy? Classifying an intermediate state? Triggering treatment? Or identifying a concentration that has been shown to maximise a particular outcome?

Vitamin D Insufficiency Explained and Vitamin D Sufficiency Explained occupy the same continuum but answer different interpretive questions. That is exactly why a deficiency threshold should not silently become a functional target.

The scientifically defensible sequence is: establish that low status carries meaningful risk; define the purpose of the threshold; then separately ask whether raising status above that threshold produces additional benefit. Only when that final proposition is supported does a higher functional target earn its place.

Scientific sources

Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53-58. PMID: 21118827. PMCID: PMC3046611. DOI: 10.1210/jc.2010-2704.

Gallagher JC, Yalamanchili V, Smith LM. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550-3556. PMID: 22855333. PMCID: PMC3462946. DOI: 10.1210/jc.2012-2020.

McCartney CR, McDonnell ME, Corrigan MD, Lash RW. Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1948-1954. DOI: 10.1210/clinem/dgae322.

Related reading

Original sources

Source

The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know

Published in Journal of Clinical Endocrinology & Metabolism (2011).

Publication details

Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53-58. PMID: 21118827. PMCID: PMC3046611. DOI: 10.1210/jc.2010-2704.

Read more →
Source

The Effect of Vitamin D on Calcium Absorption in Older Women

Published in Journal of Clinical Endocrinology & Metabolism (2012).

Publication details

Gallagher JC, Yalamanchili V, Smith LM. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550-3556. PMID: 22855333. PMCID: PMC3462946. DOI: 10.1210/jc.2012-2020.

Read more →